hVEGF-IN-1
CAS: 1637443-98-1
Ref. 3D-MQC44398
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
hVEGF-IN-1 is a recombinant human vascular endothelial growth factor (VEGF) that has been shown to be effective in the treatment of diabetic nephropathy. It acts by binding to VEGF receptors on the surface of cells, which triggers an intracellular signalling cascade that leads to increased blood flow and angiogenesis. hVEGF-IN-1 has also been shown to inhibit tnf-α, p-akt, and transcriptional activity in cultured human endothelial cells. This drug has been shown to have a significant inhibitory effect on inflammation by suppressing the expression of proinflammatory cytokines such as IL-6 and TNF-α. hVEGF-IN-1 may also decrease apoptosis and cell death induced by high glucose levels.
Chemical properties
Technical inquiry about: 3D-MQC44398 hVEGF-IN-1
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
